Parathyroid disorders
Written 17th June 2020 - Last Update 19th July 2026
Parathyroid disorders
See also Hyper/hypocalcaemia for the acute calcium-disturbance work-up.
Calcium physiology (the PTH loop)
A fall in serum calcium triggers the parathyroids to release PTH, which:
- makes the kidney retain calcium and excrete phosphate,
- drives bone to release calcium, and
- (via activated vitamin D) increases gut calcium absorption.
Interpreting results turns on measuring PTH alongside calcium:
- High calcium + high (or inappropriately normal) PTH → a parathyroid problem (primary hyperparathyroidism).
- High calcium + low PTH → PTH-independent hypercalcaemia (look elsewhere — commonly malignancy).
- Normal calcium + high PTH → secondary hyperparathyroidism (the parathyroid is compensating for low calcium availability, e.g. vitamin D deficiency).
Primary hyperparathyroidism
Usually a single parathyroid adenoma. Suspect in any patient with hypercalcaemia (“bones, moans, stones and abdominal groans”): fatigue, cognitive change, renal calculi. Calcium is elevated but rises slowly; PTH is high or inappropriately high-normal; fasting phosphate is low/low-normal.
Investigations: corrected calcium (CMP), UEC, albumin/creatinine ratio, vitamin D, PTH, and a bone density scan. Imaging is not needed for diagnosis — only for surgical planning, on specialist advice.
Management — definitive therapy is surgery (parathyroidectomy). Refer for surgery with renal calculi, renal impairment, or corrected calcium >0.25 mmol/L above the reference range. A watch-and-wait approach suits patients over 50 with all of: corrected calcium <2.9 mmol/L, normal kidney function, no nephrolithiasis/nephrocalcinosis, BMD T-score > −2.5, and no symptoms — about 50% avoid surgery over 10 years. For conservative management:
- monitor calcium and kidney function every 6–12 months, BMD every 2 years;
- avoid high calcium intake; limit vitamin D supplementation to 1000 IU (25 microgram)/day if needed for deficiency; keep water intake high (~2.5 L/day).
Refer patients younger than 40 for genetic testing.
Secondary and tertiary hyperparathyroidism
- Secondary — normal calcium, high PTH; typically from vitamin D deficiency or chronic kidney disease. Much more common than primary — treat the underlying cause and correct vitamin D first. Thiazides increase calcium retention and can unmask/worsen hypercalcaemia.
- Tertiary — prolonged secondary stimulation (usually CKD or post-transplant) becomes autonomous, producing hypercalcaemia; often needs partial parathyroidectomy.
Familial hypocalciuric hypercalcaemia (FHH)
Benign, familial, not dangerous. Only needs diagnosing if surgery is being considered (to avoid a futile parathyroidectomy) — urinary calcium is used to identify it. Otherwise don’t chase it.
Hypoparathyroidism
The commonest cause of hypocalcaemia. Causes: postoperative (thyroidectomy/ parathyroidectomy), congenital (DiGeorge syndrome), and idiopathic autoimmune. Features: neuromuscular hyperexcitability, tetany, and neuropsychiatric manifestations — see Hyper/hypocalcaemia.
Practical pearls
- Vitamin D toxicity is possible from oral colecalciferol, and more readily from calcitriol (acts directly on the gut).
- Calcium citrate is absorbed independent of gastric acidity — useful on a PPI.
- Emergency hypercalcaemia: calcium >3.5 mmol/L (or >3 with symptoms) needs urgent management.
- If PTH-independent hypercalcaemia has no obvious cause, look for malignancy; if still unclear, seek specialist advice.